Keywords: roche, actemra, beats, mtx, new, ra, studies

Roche's Actemra beats MTX in new RA studies

Article | 30 June 2008

Print This

Swiss drug major Roche's Actemra (tocilizumab) has shown superiority compared against the current standard of care, methotrexate, in new data ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in